相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cdc6 as a novel target in cancer: Oncogenic potential, senescence and subcellular localisation
Nicholas Lim et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition
Xiaohui Yu et al.
ONCOGENE (2019)
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
E. David Crawford et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
Linglong Yin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
Bowen Yuan et al.
CELL DEATH & DISEASE (2018)
Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a
Kun-Yong Kim et al.
NATURE COMMUNICATIONS (2018)
UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics
Harsimran Sidhu et al.
TUMOR BIOLOGY (2017)
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Youxiang Hou et al.
CELL DEATH & DISEASE (2017)
Mechanisms of Therapeutic Resistance in Prostate Cancer
Mary Nakazawa et al.
CURRENT ONCOLOGY REPORTS (2017)
The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer
Waseem Ashraf et al.
ONCOTARGET (2017)
Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer
Zoran Culig
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells
Youhong Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
KDM4C (GASC1) lysine demethylase is associated with mitotic chromatin and regulates chromosome segregation during mitosis
Ilana Kupershmit et al.
NUCLEIC ACIDS RESEARCH (2014)
Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis
Christian Bronner et al.
BIOCHEMICAL PHARMACOLOGY (2013)
KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
William L. Berry et al.
CANCER RESEARCH (2013)
Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma
Congrong Yang et al.
MOLECULAR BIOLOGY REPORTS (2013)
The emerging role of histone lysine demethylases in prostate cancer
Francesco Crea et al.
MOLECULAR CANCER (2012)
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression
F. Babbio et al.
ONCOGENE (2012)
UHRF1 confers radioresistance to human breast cancer cells
Xinli Li et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2011)
Mechanism of androgen receptor action
Jin Li et al.
MATURITAS (2009)
A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression
Feng Jin et al.
NUCLEIC ACIDS RESEARCH (2009)
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
William P. Harris et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix
Hideharu Hashimoto et al.
NATURE (2008)
Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism
Kyohei Arita et al.
NATURE (2008)
CDC6:: from DNA replication to cell cycle checkpoints and oncogenesis
Luis R. Borlado et al.
CARCINOGENESIS (2008)
Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors
Myles C. Hodgson et al.
CANCER RESEARCH (2007)
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
Melanie Wissmann et al.
NATURE CELL BIOLOGY (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
分享论文
